GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (FRA:UJ9) » Definitions » Common Stock

Shandong Boan Biotechnology Co (FRA:UJ9) Common Stock : €65.22 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shandong Boan Biotechnology Co Common Stock?

Shandong Boan Biotechnology Co's quarterly common stock declined from Jun. 2023 (€65.64 Mil) to Dec. 2023 (€65.41 Mil) and declined from Dec. 2023 (€65.41 Mil) to Jun. 2024 (€65.22 Mil).

Shandong Boan Biotechnology Co's annual common stock declined from Dec. 2021 (€69.28 Mil) to Dec. 2022 (€68.96 Mil) and declined from Dec. 2022 (€68.96 Mil) to Dec. 2023 (€65.41 Mil).


Shandong Boan Biotechnology Co Common Stock Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Common Stock Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Common Stock
45.25 69.28 68.96 65.41

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial 70.45 68.96 65.64 65.41 65.22

Shandong Boan Biotechnology Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Shandong Boan Biotechnology Co Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co Headlines

No Headlines